India and also the patent wars: pharmaceuticals within the new ip regime on jstor
India and also the Patent Wars plays a role in an worldwide debate within the costs of drugs and limitations on access under stringent patent laws and regulations showing how activists and drug companies in low-earnings countries seize agency and exert influence of these processes. Murphy Halliburton plays a role in analyses of globalization inside the fields of anthropology, sociology, law, and public health by applying interviews and ethnographic use pharmaceutical producers in India and also the U . s . States.
India continues to be in the center of emerging controversies around patent legal rights associated with pharmaceutical production and native medical understanding. Halliburton implies that Big Pharma isn’t all-effective, which local activists and practitioners of ayurveda, India‘s largest indigenous medical system, have had the ability to undermine the aspirations of multinational companies and also the WTO. Halliburton traces how key drug prices go lower, not up, in low-earnings countries underneath the new patent regime through partnerships between US- and India-based companies, but warns us to understand use of essential medicines in low- and middle-earnings countries moving forward.